Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Change in Inventory: 2015-2025

Historic Change in Inventory for Aytu Biopharma (AYTU) over the last 11 years, with Jun 2025 value amounting to -$382,000.

  • Aytu Biopharma's Change in Inventory fell 216.17% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 132.80%. This contributed to the annual value of -$382,000 for FY2025, which is 107.92% down from last year.
  • Aytu Biopharma's Change in Inventory amounted to -$382,000 in FY2025, which was down 107.92% from $4.8 million recorded in FY2024.
  • Aytu Biopharma's Change in Inventory's 5-year high stood at $4.8 million during FY2024, with a 5-year trough of -$2.8 million in FY2021.
  • Moreover, its 3-year median value for Change in Inventory was $3.6 million (2023), whereas its average is $2.7 million.
  • As far as peak fluctuations go, Aytu Biopharma's Change in Inventory crashed by 133.91% in 2021, and later skyrocketed by 377.83% in 2023.
  • Aytu Biopharma's Change in Inventory (Yearly) stood at -$2.8 million in 2021, then soared by 53.37% to -$1.3 million in 2022, then soared by 377.83% to $3.6 million in 2023, then skyrocketed by 33.58% to $4.8 million in 2024, then plummeted by 107.92% to -$382,000 in 2025.